Chinese AI Startup DP Technology Uses AI to Streamline Drug R&D, Eyes Expansion Despite Geopolitical Tensions
• Chinese AI startup DP Technology uses AI to improve speed and accuracy of molecular simulations for R&D efficiency
• Provides software platforms for computational research and drug discovery, plus tailored services
• Revenue grew to ~$14M in 2023; now expanding to US and other Western markets
• Founded in 2018, has raised ~$140M from top Chinese VCs
• Aims to leverage open source community and reputation in research circles for US growth despite geopolitical tensions